<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08647</article-id><article-id pub-id-type="doi">10.7554/eLife.08647</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>KPNB1 mediates PER/CRY nuclear translocation and circadian clock function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-34114"><name><surname>Lee</surname><given-names>Yool</given-names></name><aff><institution content-type="dept">Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics</institution>, <institution>Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34115"><name><surname>Jang</surname><given-names>A Reum</given-names></name><aff><institution content-type="dept">Department of Neuroscience</institution>, <institution>Howard Hughes Medical Institute, University of Pennsylvania Perelman School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34116"><name><surname>Francey</surname><given-names>Lauren J</given-names></name><aff><institution content-type="dept">Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics</institution>, <institution>Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4923"><name><surname>Sehgal</surname><given-names>Amita</given-names></name><aff><institution content-type="dept">Department of Neuroscience</institution>, <institution>Howard Hughes Medical Institute, University of Pennsylvania Perelman School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1411"><name><surname>Hogenesch</surname><given-names>John B</given-names></name><aff><institution content-type="dept">Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics</institution>, <institution>Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country><email>hogenesc@mail.med.upenn.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11736"><name><surname>Kramer</surname><given-names>Achim</given-names></name><role>Reviewing editor</role><aff><institution> </institution>, <country> </country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>08</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e08647</elocation-id><supplementary-material><ext-link xlink:href="elife-08647-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>11</day><month>05</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Lee et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Lee et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Regulated nuclear translocation of the PER/CRY repressor complex is critical for negative feedback regulation of the circadian clock of mammals. However, the precise molecular mechanism is not fully understood. Here, we report that KPNB1, an importin β component of the ncRNA repressor of NFAT (NRON) ribonucleoprotein (RNP) complex, mediates nuclear translocation and repressor function of the PER/CRY complex. RNAi depletion of KPNB1 trapped the PER/CRY complex in cytoplasm by blocking nuclear entry of PER proteins in human cells. KPNB1 interacted mainly with PER proteins and directed PER/CRY nuclear transport in circadian fashion. Interestingly, KPNB1 regulated the PER/CRY nuclear entry and repressor function, independently of importin α, its classical partner. Moreover, inducible inhibition of the conserved <italic>Drosophila</italic> importin β in lateral neurons abolished behavioral rhythms in flies. Collectively, these data show that KPNB1 is required for timely nuclear import of PER/CRY in the negative feedback regulation of circadian clock.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>